{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:16:21Z","timestamp":1764479781265,"version":"3.46.0"},"reference-count":24,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>There is a high burden of respiratory symptoms in South Africa, but accurate classification of diagnoses is challenging. Due to the adverse risk profile, inhaled corticosteroid (ICS) treatment should only be used in specific conditions, such as asthma or chronic obstructive pulmonary disease (COPD) with eosinophilia. Those with tuberculosis or who are HIV\u2010positive may be at particular risk. Hence, establishing underlying diagnoses and indications for ICS treatment is crucial. The primary aim was to establish the underlying diagnosis after investigations, the secondary aim was to identify any indication for ICS treatment (asthma or eosinophilia).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross\u2010sectional study of adults attending two hospitals in Cape Town, South Africa, with exacerbations of chronic respiratory diseases. Participants performed investigations at least 8 weeks after recruitment. Questionnaires and extensive investigations (full lung function with bronchodilator reversibility, allergy tests, computed tomography) were completed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2021 and 2023, a total of 224 participants were recruited, of whom 101 attended investigations, yet 40 died before they could attend. Most were current (49) or ex\u2010smokers (40). A total of 46 previously had pulmonary tuberculosis. Post\u2010tuberculosis lung disease (PTLD) with COPD (28) or COPD alone (27) were the most common diagnoses. Ten participants had asthma. Serum eosinophilia was present in 19 participants. There was no clear indication for ICS treatment for 5\/7 participants who used ICS, and 22\/30 who used ICS\u2010long\u2010acting beta\u2010agonists combination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COPD and PTLD were more common, asthma and eosinophilia were less prevalent than expected. There was a high symptom burden. Modifiable risks (tuberculosis, smoking) were also common. ICS treatment appeared to be independent of underlying diagnosis and could lead to harm. Approximately 1 in 5 died shortly after admission. Strategies to better serve this patient group are urgently needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hsr2.70992","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T13:23:58Z","timestamp":1752067438000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Respiratory Disease Prevalence, Burden, and Treatment in Cape Town: A Cross\u2010Sectional Study"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6091-9316","authenticated-orcid":false,"given":"Marie","family":"Stolbrink","sequence":"first","affiliation":[{"name":"Department of Lung Health and Tuberculosis, Clinical Sciences Liverpool School of Tropical Medicine Liverpool UK"},{"name":"Division of Pulmonology, Department of Medicine Stellenbosch University Stellenbosch South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisanne","family":"Liebenberg","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Medicine Stellenbosch University Stellenbosch South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tantaswa","family":"Ndlelana","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Medicine Stellenbosch University Stellenbosch South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kischa","family":"Petersen","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Medicine Stellenbosch University Stellenbosch South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Griffith\u2010Richards","sequence":"additional","affiliation":[{"name":"Radiology Department Tygerberg Academic Hospital Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Mortimer","sequence":"additional","affiliation":[{"name":"Cambridge Africa, Department of Pathology University of Cambridge Cambridge UK"},{"name":"School of Clinical Medicine, College of Health Sciences University of KwaZulu\u2010Natal Durban South Africa"},{"name":"Liverpool University Hospitals NHS Foundation Trust Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Allwood","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Medicine Stellenbosch University Stellenbosch South Africa"},{"name":"Department of Pulmonology Tygerberg Hospital Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00004-1"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01450-1"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0394"},{"key":"e_1_2_12_5_1","unstructured":"Global Asthma Network. \u201cGlobal Asthma Report 2022 \u201d International Journal of Tuberculosis and Lung Disease (2022)."},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(11)19"},{"key":"e_1_2_12_7_1","unstructured":"Global Initiative for Asthma. \u201cGlobal Strategy for Asthma Management and Prevention \u201d Global Initiative for Asthma (2022)."},{"key":"e_1_2_12_8_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. \u201cGlobal Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease \u201d Global Initiative for Chronic Obstructive Lung Disease (2023)."},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.01.025"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010115.pub2"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.10.007"},{"volume-title":"CDC Division of Global HIV & TB Country Profile: South Africa","year":"2022","author":"CDC Division of Global HIV & TB activities","key":"e_1_2_12_12_1"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(06)80166-6"},{"key":"e_1_2_12_14_1","first-page":"337","volume-title":"Annals of Medicine","author":"Rabin R.","year":"2001"},{"key":"e_1_2_12_15_1","unstructured":"J.RylanceIMPALA Questionnaires.2020 https:\/\/github.com\/jipp3r\/IMPALA_QuestionSet."},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00277-0"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_2_12_19_1","unstructured":"R Core Team R: A Language and Environment for Statistical Computing.2021."},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.10.65"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2014.07.03"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01391-2014"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213808"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v20i1.984"},{"key":"e_1_2_12_25_1","unstructured":"World Bank World Development Indicators.2023."}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.70992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:14:51Z","timestamp":1764479691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.70992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/hsr2.70992"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.70992","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"type":"print","value":"2398-8835"},{"type":"electronic","value":"2398-8835"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70992"}}